

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 5.77809989 |
| 2 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 5.77809989 |
| 3 | negative regulation of dendrite morphogenesis (GO:0050774) | 5.51500347 |
| 4 | detection of temperature stimulus (GO:0016048) | 5.34918081 |
| 5 | membrane depolarization during action potential (GO:0086010) | 5.16231968 |
| 6 | neuronal action potential (GO:0019228) | 4.86702443 |
| 7 | urinary tract smooth muscle contraction (GO:0014848) | 4.84158189 |
| 8 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.52322963 |
| 9 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.50750002 |
| 10 | glutamate secretion (GO:0014047) | 4.29836732 |
| 11 | acrosome reaction (GO:0007340) | 4.28387343 |
| 12 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 4.24394909 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.18196298 |
| 14 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.17928589 |
| 15 | cell migration in hindbrain (GO:0021535) | 4.12681923 |
| 16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.12397113 |
| 17 | peripheral nervous system neuron development (GO:0048935) | 4.05290218 |
| 18 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.01358077 |
| 19 | negative regulation of dendrite development (GO:2000171) | 3.96500717 |
| 20 | calcium ion-dependent exocytosis (GO:0017156) | 3.94729858 |
| 21 | proline transport (GO:0015824) | 3.92879985 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.84957554 |
| 23 | regulation of pigment cell differentiation (GO:0050932) | 3.83095438 |
| 24 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.78054709 |
| 25 | protein localization to synapse (GO:0035418) | 3.75268336 |
| 26 | response to pain (GO:0048265) | 3.74567191 |
| 27 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.62682016 |
| 28 | interkinetic nuclear migration (GO:0022027) | 3.60637476 |
| 29 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.59010558 |
| 30 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.55144380 |
| 31 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.53458608 |
| 32 | synaptic vesicle maturation (GO:0016188) | 3.51668859 |
| 33 | inositol phosphate-mediated signaling (GO:0048016) | 3.51376644 |
| 34 | synaptic vesicle exocytosis (GO:0016079) | 3.46927745 |
| 35 | cilium movement (GO:0003341) | 3.44566487 |
| 36 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.40946972 |
| 37 | positive regulation of developmental pigmentation (GO:0048087) | 3.40576796 |
| 38 | behavioral response to pain (GO:0048266) | 3.39233883 |
| 39 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.38319852 |
| 40 | membrane depolarization (GO:0051899) | 3.35855704 |
| 41 | relaxation of cardiac muscle (GO:0055119) | 3.34648580 |
| 42 | neuronal action potential propagation (GO:0019227) | 3.33382392 |
| 43 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.32737721 |
| 44 | pericardium development (GO:0060039) | 3.32434179 |
| 45 | neuromuscular synaptic transmission (GO:0007274) | 3.31626432 |
| 46 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.31201136 |
| 47 | positive regulation of muscle hypertrophy (GO:0014742) | 3.31138863 |
| 48 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.31138863 |
| 49 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.27952890 |
| 50 | dopamine receptor signaling pathway (GO:0007212) | 3.26600768 |
| 51 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.25846126 |
| 52 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.25463288 |
| 53 | nerve growth factor signaling pathway (GO:0038180) | 3.24964101 |
| 54 | regulation of synaptic vesicle transport (GO:1902803) | 3.21090354 |
| 55 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.19068746 |
| 56 | motile cilium assembly (GO:0044458) | 3.17012076 |
| 57 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.16474861 |
| 58 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.14082606 |
| 59 | vocalization behavior (GO:0071625) | 3.12586700 |
| 60 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.11938378 |
| 61 | synaptic transmission, glutamatergic (GO:0035249) | 3.11728425 |
| 62 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.10358597 |
| 63 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.09290265 |
| 64 | retina layer formation (GO:0010842) | 3.08844403 |
| 65 | vesicle transport along microtubule (GO:0047496) | 3.08453734 |
| 66 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.07351860 |
| 67 | axonemal dynein complex assembly (GO:0070286) | 3.07167541 |
| 68 | glutamate receptor signaling pathway (GO:0007215) | 3.06166229 |
| 69 | neuron cell-cell adhesion (GO:0007158) | 3.05135968 |
| 70 | lipid translocation (GO:0034204) | 3.04557216 |
| 71 | phospholipid translocation (GO:0045332) | 3.04557216 |
| 72 | sympathetic nervous system development (GO:0048485) | 3.03956897 |
| 73 | sperm motility (GO:0030317) | 3.03872300 |
| 74 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.03611034 |
| 75 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.03059773 |
| 76 | acrosome assembly (GO:0001675) | 3.02984558 |
| 77 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.00391577 |
| 78 | behavioral response to ethanol (GO:0048149) | 3.00362376 |
| 79 | establishment of protein localization to Golgi (GO:0072600) | 2.99622080 |
| 80 | behavioral response to nicotine (GO:0035095) | 2.99483982 |
| 81 | neuron-neuron synaptic transmission (GO:0007270) | 2.97948487 |
| 82 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.97374030 |
| 83 | innervation (GO:0060384) | 2.95811876 |
| 84 | cell communication involved in cardiac conduction (GO:0086065) | 2.95344900 |
| 85 | regulation of hippo signaling (GO:0035330) | 2.94988453 |
| 86 | locomotory exploration behavior (GO:0035641) | 2.94141740 |
| 87 | action potential (GO:0001508) | 2.93317559 |
| 88 | neurofilament cytoskeleton organization (GO:0060052) | 2.92444461 |
| 89 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.89246480 |
| 90 | regulation of establishment of cell polarity (GO:2000114) | 2.88795052 |
| 91 | chemosensory behavior (GO:0007635) | 2.88153626 |
| 92 | snRNA transcription (GO:0009301) | 2.86399084 |
| 93 | nucleus localization (GO:0051647) | 2.85499641 |
| 94 | multicellular organismal movement (GO:0050879) | 2.85172099 |
| 95 | musculoskeletal movement (GO:0050881) | 2.85172099 |
| 96 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.84672871 |
| 97 | response to water (GO:0009415) | 2.83162833 |
| 98 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.83115524 |
| 99 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.82810544 |
| 100 | presynaptic membrane assembly (GO:0097105) | 2.82414113 |
| 101 | peristalsis (GO:0030432) | 2.81139252 |
| 102 | cellular response to ethanol (GO:0071361) | 2.81056798 |
| 103 | regulation of neurotransmitter secretion (GO:0046928) | 2.80847868 |
| 104 | detection of calcium ion (GO:0005513) | 2.80426892 |
| 105 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.80265140 |
| 106 | activation of adenylate cyclase activity (GO:0007190) | 2.79794530 |
| 107 | regulation of postsynaptic membrane potential (GO:0060078) | 2.79086076 |
| 108 | multicellular organismal response to stress (GO:0033555) | 2.77991441 |
| 109 | epithelial cilium movement (GO:0003351) | 2.77459267 |
| 110 | smooth muscle tissue development (GO:0048745) | 2.77373528 |
| 111 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.76086542 |
| 112 | negative regulation of complement activation (GO:0045916) | 2.74937619 |
| 113 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.74773451 |
| 114 | cellular potassium ion homeostasis (GO:0030007) | 2.73621447 |
| 115 | retinal cone cell development (GO:0046549) | 2.72783354 |
| 116 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.72312352 |
| 117 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.71745528 |
| 118 | primary amino compound metabolic process (GO:1901160) | 2.70976011 |
| 119 | activation of protein kinase A activity (GO:0034199) | 2.70925597 |
| 120 | regulation of protein kinase A signaling (GO:0010738) | 2.70884957 |
| 121 | plasma membrane fusion (GO:0045026) | 2.70557491 |
| 122 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.70193230 |
| 123 | protein polyglutamylation (GO:0018095) | 2.69930564 |
| 124 | protein localization to cilium (GO:0061512) | 2.69926486 |
| 125 | exploration behavior (GO:0035640) | 2.69360871 |
| 126 | neurotransmitter secretion (GO:0007269) | 2.68581457 |
| 127 | cellular response to ATP (GO:0071318) | 2.68237670 |
| 128 | organelle transport along microtubule (GO:0072384) | 2.67719795 |
| 129 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.66910934 |
| 130 | lymphangiogenesis (GO:0001946) | 2.65163001 |
| 131 | positive regulation of fibroblast migration (GO:0010763) | 2.64613184 |
| 132 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.64534904 |
| 133 | positive regulation of adenylate cyclase activity (GO:0045762) | 2.62819899 |
| 134 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.62316739 |
| 135 | negative regulation of microtubule polymerization (GO:0031115) | 2.61589454 |
| 136 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.60706269 |
| 137 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.57297030 |
| 138 | protein K48-linked deubiquitination (GO:0071108) | 2.57044460 |
| 139 | positive regulation of phosphatase activity (GO:0010922) | 2.56859298 |
| 140 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.56106251 |
| 141 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.56106251 |
| 142 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.56106251 |
| 143 | auditory receptor cell differentiation (GO:0042491) | 2.54769233 |
| 144 | metanephric nephron tubule development (GO:0072234) | 2.50855438 |
| 145 | metanephric tubule development (GO:0072170) | 2.50855438 |
| 146 | axoneme assembly (GO:0035082) | 2.48843685 |
| 147 | renal tubule morphogenesis (GO:0061333) | 2.48713485 |
| 148 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.45896523 |
| 149 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.45387698 |
| 150 | prenylation (GO:0097354) | 2.44748374 |
| 151 | protein prenylation (GO:0018342) | 2.44748374 |
| 152 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.42771490 |
| 153 | regulation of alkaline phosphatase activity (GO:0010692) | 2.42761935 |
| 154 | regulation of centriole replication (GO:0046599) | 2.42435833 |
| 155 | Golgi to endosome transport (GO:0006895) | 2.38715178 |
| 156 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.37881925 |
| 157 | embryonic foregut morphogenesis (GO:0048617) | 2.37763296 |
| 158 | metanephric nephron epithelium development (GO:0072243) | 2.37610791 |
| 159 | cilium organization (GO:0044782) | 2.37318250 |
| 160 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.34324867 |
| 161 | relaxation of muscle (GO:0090075) | 2.33513800 |
| 162 | cilium assembly (GO:0042384) | 2.33386195 |
| 163 | negative regulation of fatty acid transport (GO:2000192) | 2.32288824 |
| 164 | intestinal epithelial cell development (GO:0060576) | 2.31779079 |
| 165 | left/right axis specification (GO:0070986) | 2.31043777 |
| 166 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.30624036 |
| 167 | ovulation from ovarian follicle (GO:0001542) | 2.30463225 |
| 168 | early endosome to late endosome transport (GO:0045022) | 2.30258230 |
| 169 | regulation of sarcomere organization (GO:0060297) | 2.29723904 |
| 170 | protein K11-linked deubiquitination (GO:0035871) | 2.27276770 |
| 171 | atrial cardiac muscle cell action potential (GO:0086014) | 2.26529570 |
| 172 | protein targeting to lysosome (GO:0006622) | 2.25270309 |
| 173 | establishment of protein localization to vacuole (GO:0072666) | 2.25270309 |
| 174 | protein targeting to vacuole (GO:0006623) | 2.25270309 |
| 175 | positive regulation of cation channel activity (GO:2001259) | 2.24580954 |
| 176 | protein targeting to Golgi (GO:0000042) | 2.24260115 |
| 177 | replicative senescence (GO:0090399) | 2.24215772 |
| 178 | keratinocyte proliferation (GO:0043616) | 2.24096941 |
| 179 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.23884913 |
| 180 | cGMP metabolic process (GO:0046068) | 2.23759725 |
| 181 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.23608737 |
| 182 | regulation of protein polyubiquitination (GO:1902914) | 2.23461689 |
| 183 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.23149140 |
| 184 | serotonin metabolic process (GO:0042428) | 2.21587140 |
| 185 | artery development (GO:0060840) | 2.21478467 |
| 186 | histone H3-K4 trimethylation (GO:0080182) | 2.20518267 |
| 187 | striated muscle atrophy (GO:0014891) | 2.20385246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.15371017 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.84362231 |
| 3 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.79072501 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.54242079 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 2.43305678 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.33941050 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.32954527 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.24101224 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.23888537 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.23836936 |
| 11 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.12937725 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.11045178 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.11018721 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.08161883 |
| 15 | SMAD4_21799915_ChIP-Seq_A2780_Human | 2.08033065 |
| 16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.06325725 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.98758710 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.98064762 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.97715190 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.96652163 |
| 21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96275237 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.93158226 |
| 23 | TP53_16413492_ChIP-PET_HCT116_Human | 1.93150870 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.89270635 |
| 25 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.89270635 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.87617195 |
| 27 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.83997653 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.82496424 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.79042951 |
| 30 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.78837863 |
| 31 | EWS_26573619_Chip-Seq_HEK293_Human | 1.73377792 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.69629747 |
| 33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68818064 |
| 34 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.68084032 |
| 35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.66697656 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.66165769 |
| 37 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.62982729 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61761253 |
| 39 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.61561285 |
| 40 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.60501289 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.60225673 |
| 42 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.58352166 |
| 43 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.57922102 |
| 44 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.56470096 |
| 45 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.56084587 |
| 46 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.54530157 |
| 47 | STAT3_23295773_ChIP-Seq_U87_Human | 1.54106013 |
| 48 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.53724210 |
| 49 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.53093423 |
| 50 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.52305220 |
| 51 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.52265750 |
| 52 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.51509635 |
| 53 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.50959452 |
| 54 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.50068212 |
| 55 | AR_25329375_ChIP-Seq_VCAP_Human | 1.48628206 |
| 56 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.47610049 |
| 57 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.43751838 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.42215504 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.42215504 |
| 60 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38558037 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38155881 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37784328 |
| 63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37647452 |
| 64 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.36521630 |
| 65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34548981 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.34153615 |
| 67 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33544247 |
| 68 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33193570 |
| 69 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32947002 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.32218196 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.31976697 |
| 72 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30737610 |
| 73 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.29864359 |
| 74 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28598513 |
| 75 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28506152 |
| 76 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.28364047 |
| 77 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28364047 |
| 78 | KDM2B_26808549_Chip-Seq_REH_Human | 1.27129079 |
| 79 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26734379 |
| 80 | CJUN_26792858_Chip-Seq_BT549_Human | 1.26046803 |
| 81 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25150680 |
| 82 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23910763 |
| 83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.23249812 |
| 84 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22403423 |
| 85 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.22238383 |
| 86 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21940336 |
| 87 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21029199 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.20079629 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20041903 |
| 90 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.19741674 |
| 91 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18741839 |
| 92 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.18651647 |
| 93 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18328829 |
| 94 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.18192792 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18173958 |
| 96 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18159059 |
| 97 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.17561656 |
| 98 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.17410749 |
| 99 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.17079428 |
| 100 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17023524 |
| 101 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16106170 |
| 102 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.16072385 |
| 103 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.14751528 |
| 104 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14245724 |
| 105 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.13797095 |
| 106 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.12564371 |
| 107 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12277594 |
| 108 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.11291124 |
| 109 | AR_19668381_ChIP-Seq_PC3_Human | 1.11002431 |
| 110 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10983201 |
| 111 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.10860306 |
| 112 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10357103 |
| 113 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07260225 |
| 114 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.07037409 |
| 115 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06665444 |
| 116 | JUN_21703547_ChIP-Seq_K562_Human | 1.06182536 |
| 117 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06141383 |
| 118 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05992527 |
| 119 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05992527 |
| 120 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05575388 |
| 121 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.05573214 |
| 122 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04564498 |
| 123 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.04355932 |
| 124 | FUS_26573619_Chip-Seq_HEK293_Human | 1.04269575 |
| 125 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04127382 |
| 126 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03876903 |
| 127 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.03723735 |
| 128 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03591445 |
| 129 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.03364754 |
| 130 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.02387931 |
| 131 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01648652 |
| 132 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.00179635 |
| 133 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99991585 |
| 134 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99876854 |
| 135 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98696640 |
| 136 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98601033 |
| 137 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.98418882 |
| 138 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96619087 |
| 139 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96442948 |
| 140 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.96221217 |
| 141 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96136059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001968_abnormal_touch/_nociception | 6.24245194 |
| 2 | MP0002735_abnormal_chemical_nociception | 6.18229563 |
| 3 | MP0002736_abnormal_nociception_after | 5.07451832 |
| 4 | MP0004270_analgesia | 4.61174829 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 4.15344193 |
| 6 | MP0001986_abnormal_taste_sensitivity | 3.70849195 |
| 7 | MP0008057_abnormal_DNA_replication | 3.68293238 |
| 8 | MP0002734_abnormal_mechanical_nocicepti | 3.59541639 |
| 9 | MP0006276_abnormal_autonomic_nervous | 3.57776049 |
| 10 | MP0002733_abnormal_thermal_nociception | 3.56487894 |
| 11 | MP0004858_abnormal_nervous_system | 3.26041973 |
| 12 | MP0000383_abnormal_hair_follicle | 3.21224104 |
| 13 | MP0003950_abnormal_plasma_membrane | 3.13992761 |
| 14 | MP0001970_abnormal_pain_threshold | 3.04801142 |
| 15 | MP0004084_abnormal_cardiac_muscle | 2.91221088 |
| 16 | MP0010678_abnormal_skin_adnexa | 2.88485443 |
| 17 | MP0003880_abnormal_central_pattern | 2.79889003 |
| 18 | MP0003635_abnormal_synaptic_transmissio | 2.79122110 |
| 19 | MP0005410_abnormal_fertilization | 2.60399337 |
| 20 | MP0009745_abnormal_behavioral_response | 2.55194373 |
| 21 | MP0001879_abnormal_lymphatic_vessel | 2.41678631 |
| 22 | MP0002272_abnormal_nervous_system | 2.35310897 |
| 23 | MP0004043_abnormal_pH_regulation | 2.31820844 |
| 24 | MP0009046_muscle_twitch | 2.30520457 |
| 25 | MP0002063_abnormal_learning/memory/cond | 2.25382389 |
| 26 | MP0002067_abnormal_sensory_capabilities | 2.15085745 |
| 27 | MP0002572_abnormal_emotion/affect_behav | 2.12413162 |
| 28 | MP0003787_abnormal_imprinting | 2.09462939 |
| 29 | MP0002822_catalepsy | 2.05042677 |
| 30 | MP0002009_preneoplasia | 2.02368414 |
| 31 | MP0002064_seizures | 2.00770451 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.97327140 |
| 33 | MP0010386_abnormal_urinary_bladder | 1.92565789 |
| 34 | MP0004742_abnormal_vestibular_system | 1.91945920 |
| 35 | MP0005187_abnormal_penis_morphology | 1.91013063 |
| 36 | MP0002184_abnormal_innervation | 1.84273063 |
| 37 | MP0001440_abnormal_grooming_behavior | 1.79571415 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.77553268 |
| 39 | MP0002751_abnormal_autonomic_nervous | 1.71342663 |
| 40 | MP0003890_abnormal_embryonic-extraembry | 1.69638916 |
| 41 | MP0002168_other_aberrant_phenotype | 1.69616848 |
| 42 | MP0004811_abnormal_neuron_physiology | 1.46367929 |
| 43 | MP0001984_abnormal_olfaction | 1.42034279 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.37685267 |
| 45 | MP0008877_abnormal_DNA_methylation | 1.34318922 |
| 46 | MP0005423_abnormal_somatic_nervous | 1.33156981 |
| 47 | MP0003122_maternal_imprinting | 1.30389450 |
| 48 | MP0000566_synostosis | 1.29486179 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.28277716 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.27142005 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.26638545 |
| 52 | MP0010234_abnormal_vibrissa_follicle | 1.24890019 |
| 53 | MP0005503_abnormal_tendon_morphology | 1.23141208 |
| 54 | MP0002160_abnormal_reproductive_system | 1.22401993 |
| 55 | MP0005310_abnormal_salivary_gland | 1.21933792 |
| 56 | MP0003633_abnormal_nervous_system | 1.21768555 |
| 57 | MP0000778_abnormal_nervous_system | 1.21018491 |
| 58 | MP0004924_abnormal_behavior | 1.20687716 |
| 59 | MP0005386_behavior/neurological_phenoty | 1.20687716 |
| 60 | MP0000955_abnormal_spinal_cord | 1.20612825 |
| 61 | MP0005551_abnormal_eye_electrophysiolog | 1.19996203 |
| 62 | MP0001905_abnormal_dopamine_level | 1.19571078 |
| 63 | MP0001486_abnormal_startle_reflex | 1.18055030 |
| 64 | MP0004272_abnormal_basement_membrane | 1.16790837 |
| 65 | MP0005174_abnormal_tail_pigmentation | 1.15331276 |
| 66 | MP0005646_abnormal_pituitary_gland | 1.12237635 |
| 67 | MP0002638_abnormal_pupillary_reflex | 1.11578079 |
| 68 | MP0005409_darkened_coat_color | 1.11217067 |
| 69 | MP0003943_abnormal_hepatobiliary_system | 1.09898928 |
| 70 | MP0005595_abnormal_vascular_smooth | 1.07920134 |
| 71 | MP0002557_abnormal_social/conspecific_i | 1.07912429 |
| 72 | MP0005620_abnormal_muscle_contractility | 1.07866625 |
| 73 | MP0003329_amyloid_beta_deposits | 1.07811510 |
| 74 | MP0005275_abnormal_skin_tensile | 1.07627933 |
| 75 | MP0002882_abnormal_neuron_morphology | 1.07386362 |
| 76 | MP0000371_diluted_coat_color | 1.05722549 |
| 77 | MP0001188_hyperpigmentation | 1.05404877 |
| 78 | MP0009780_abnormal_chondrocyte_physiolo | 1.04336220 |
| 79 | MP0003137_abnormal_impulse_conducting | 1.03337799 |
| 80 | MP0003631_nervous_system_phenotype | 1.01000259 |
| 81 | MP0000372_irregular_coat_pigmentation | 1.00455258 |
| 82 | MP0000751_myopathy | 1.00201287 |
| 83 | MP0005253_abnormal_eye_physiology | 0.99112661 |
| 84 | MP0010307_abnormal_tumor_latency | 0.98489087 |
| 85 | MP0003646_muscle_fatigue | 0.98292707 |
| 86 | MP0003941_abnormal_skin_development | 0.97356958 |
| 87 | MP0001485_abnormal_pinna_reflex | 0.94916897 |
| 88 | MP0003698_abnormal_male_reproductive | 0.94593080 |
| 89 | MP0002909_abnormal_adrenal_gland | 0.94265174 |
| 90 | MP0008872_abnormal_physiological_respon | 0.91991124 |
| 91 | MP0003879_abnormal_hair_cell | 0.90508560 |
| 92 | MP0002066_abnormal_motor_capabilities/c | 0.90373836 |
| 93 | MP0004085_abnormal_heartbeat | 0.90340207 |
| 94 | MP0001299_abnormal_eye_distance/ | 0.90003862 |
| 95 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88829515 |
| 96 | MP0003937_abnormal_limbs/digits/tail_de | 0.88697007 |
| 97 | MP0008874_decreased_physiological_sensi | 0.88608293 |
| 98 | MP0002837_dystrophic_cardiac_calcinosis | 0.88317266 |
| 99 | MP0006054_spinal_hemorrhage | 0.87783127 |
| 100 | MP0003045_fibrosis | 0.87436462 |
| 101 | MP0008961_abnormal_basal_metabolism | 0.86013110 |
| 102 | MP0008569_lethality_at_weaning | 0.85994039 |
| 103 | MP0001270_distended_abdomen | 0.85875276 |
| 104 | MP0005623_abnormal_meninges_morphology | 0.83929876 |
| 105 | MP0004484_altered_response_of | 0.83105768 |
| 106 | MP0000579_abnormal_nail_morphology | 0.81327150 |
| 107 | MP0003123_paternal_imprinting | 0.79948225 |
| 108 | MP0006072_abnormal_retinal_apoptosis | 0.78083973 |
| 109 | MP0003183_abnormal_peptide_metabolism | 0.77654592 |
| 110 | MP0005171_absent_coat_pigmentation | 0.77357874 |
| 111 | MP0000427_abnormal_hair_cycle | 0.76678083 |
| 112 | MP0002925_abnormal_cardiovascular_devel | 0.74714118 |
| 113 | MP0002928_abnormal_bile_duct | 0.74240587 |
| 114 | MP0000015_abnormal_ear_pigmentation | 0.73944156 |
| 115 | MP0009697_abnormal_copulation | 0.72750424 |
| 116 | MP0003195_calcinosis | 0.71308530 |
| 117 | MP0002109_abnormal_limb_morphology | 0.70769471 |
| 118 | MP0000538_abnormal_urinary_bladder | 0.70527846 |
| 119 | MP0004130_abnormal_muscle_cell | 0.69816518 |
| 120 | MP0005645_abnormal_hypothalamus_physiol | 0.68646443 |
| 121 | MP0004381_abnormal_hair_follicle | 0.68535247 |
| 122 | MP0002332_abnormal_exercise_endurance | 0.68142309 |
| 123 | MP0000647_abnormal_sebaceous_gland | 0.67979235 |
| 124 | MP0002108_abnormal_muscle_morphology | 0.66708554 |
| 125 | MP0001784_abnormal_fluid_regulation | 0.65657315 |
| 126 | MP0000003_abnormal_adipose_tissue | 0.64074282 |
| 127 | MP0003935_abnormal_craniofacial_develop | 0.63033298 |
| 128 | MP0000767_abnormal_smooth_muscle | 0.62513185 |
| 129 | MP0004215_abnormal_myocardial_fiber | 0.61748165 |
| 130 | MP0002752_abnormal_somatic_nervous | 0.60788759 |
| 131 | MP0004134_abnormal_chest_morphology | 0.60680490 |
| 132 | MP0001502_abnormal_circadian_rhythm | 0.60590350 |
| 133 | MP0002152_abnormal_brain_morphology | 0.59876539 |
| 134 | MP0001765_abnormal_ion_homeostasis | 0.59524367 |
| 135 | MP0001929_abnormal_gametogenesis | 0.58215412 |
| 136 | MP0002876_abnormal_thyroid_physiology | 0.57931383 |
| 137 | MP0004036_abnormal_muscle_relaxation | 0.57640627 |
| 138 | MP0003632_abnormal_nervous_system | 0.56674349 |
| 139 | MP0001529_abnormal_vocalization | 0.56122961 |
| 140 | MP0000534_abnormal_ureter_morphology | 0.54082584 |
| 141 | MP0002229_neurodegeneration | 0.53001704 |
| 142 | MP0003121_genomic_imprinting | 0.52466680 |
| 143 | MP0008775_abnormal_heart_ventricle | 0.50565362 |
| 144 | MP0005535_abnormal_body_temperature | 0.49875102 |
| 145 | MP0000230_abnormal_systemic_arterial | 0.49475976 |
| 146 | MP0002069_abnormal_eating/drinking_beha | 0.49082797 |
| 147 | MP0004145_abnormal_muscle_electrophysio | 0.48967982 |
| 148 | MP0000749_muscle_degeneration | 0.48210095 |
| 149 | MP0004142_abnormal_muscle_tone | 0.47619006 |
| 150 | MP0002161_abnormal_fertility/fecundity | 0.45987488 |
| 151 | MP0010771_integument_phenotype | 0.45265925 |
| 152 | MP0001348_abnormal_lacrimal_gland | 0.44576850 |
| 153 | MP0001963_abnormal_hearing_physiology | 0.44285761 |
| 154 | MP0001943_abnormal_respiration | 0.43067971 |
| 155 | MP0002653_abnormal_ependyma_morphology | 0.42963370 |
| 156 | MP0000604_amyloidosis | 0.42457326 |
| 157 | MP0004510_myositis | 0.42365892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.03958973 |
| 2 | Myokymia (HP:0002411) | 5.20669854 |
| 3 | Focal seizures (HP:0007359) | 4.94853277 |
| 4 | Dysmetric saccades (HP:0000641) | 4.69649423 |
| 5 | Ulnar claw (HP:0001178) | 4.62964142 |
| 6 | Action tremor (HP:0002345) | 4.32162074 |
| 7 | Dysautonomia (HP:0002459) | 4.02097251 |
| 8 | Hypothermia (HP:0002045) | 4.00782494 |
| 9 | Abnormality of pain sensation (HP:0010832) | 3.91470282 |
| 10 | Impaired pain sensation (HP:0007328) | 3.91470282 |
| 11 | Epileptic encephalopathy (HP:0200134) | 3.85920968 |
| 12 | Termporal pattern (HP:0011008) | 3.84746551 |
| 13 | Insidious onset (HP:0003587) | 3.84746551 |
| 14 | Atonic seizures (HP:0010819) | 3.78714091 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 3.77918413 |
| 16 | Febrile seizures (HP:0002373) | 3.74879671 |
| 17 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.49533689 |
| 18 | Absent/shortened dynein arms (HP:0200106) | 3.49533689 |
| 19 | Amblyopia (HP:0000646) | 3.49128739 |
| 20 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.35597597 |
| 21 | Fair hair (HP:0002286) | 3.19170797 |
| 22 | Pancreatic cysts (HP:0001737) | 3.14185367 |
| 23 | Abnormal autonomic nervous system physiology (HP:0012332) | 3.13816129 |
| 24 | Dialeptic seizures (HP:0011146) | 2.99533318 |
| 25 | Molar tooth sign on MRI (HP:0002419) | 2.99500155 |
| 26 | Abnormality of midbrain morphology (HP:0002418) | 2.99500155 |
| 27 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.98230718 |
| 28 | Absence seizures (HP:0002121) | 2.98202030 |
| 29 | Generalized tonic-clonic seizures (HP:0002069) | 2.95514826 |
| 30 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.94437716 |
| 31 | Visual hallucinations (HP:0002367) | 2.92426397 |
| 32 | Pancreatic fibrosis (HP:0100732) | 2.88921550 |
| 33 | Nephronophthisis (HP:0000090) | 2.80997143 |
| 34 | Abnormality of the renal medulla (HP:0100957) | 2.77400365 |
| 35 | Chronic hepatic failure (HP:0100626) | 2.75772776 |
| 36 | Orthostatic hypotension (HP:0001278) | 2.71813677 |
| 37 | Hypoventilation (HP:0002791) | 2.71719959 |
| 38 | Protruding tongue (HP:0010808) | 2.70147569 |
| 39 | Generalized hypopigmentation of hair (HP:0011358) | 2.69663206 |
| 40 | Bradycardia (HP:0001662) | 2.65351399 |
| 41 | True hermaphroditism (HP:0010459) | 2.65156678 |
| 42 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.63945714 |
| 43 | Ankle clonus (HP:0011448) | 2.63795111 |
| 44 | Gaze-evoked nystagmus (HP:0000640) | 2.63436003 |
| 45 | Tubular atrophy (HP:0000092) | 2.61697925 |
| 46 | Hyperkalemia (HP:0002153) | 2.59843660 |
| 47 | Hypoplastic labia majora (HP:0000059) | 2.59076919 |
| 48 | Thyroid carcinoma (HP:0002890) | 2.56001910 |
| 49 | Hammertoe (HP:0001765) | 2.55474402 |
| 50 | Abnormality of the lower motor neuron (HP:0002366) | 2.54274989 |
| 51 | Pheochromocytoma (HP:0002666) | 2.51359310 |
| 52 | Rhinitis (HP:0012384) | 2.49390363 |
| 53 | Exotropia (HP:0000577) | 2.48182688 |
| 54 | Hyperventilation (HP:0002883) | 2.44675779 |
| 55 | Abnormality of the renal cortex (HP:0011035) | 2.44100799 |
| 56 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.43212841 |
| 57 | Truncal ataxia (HP:0002078) | 2.40606813 |
| 58 | Hypercortisolism (HP:0001578) | 2.39105711 |
| 59 | Short chin (HP:0000331) | 2.39051584 |
| 60 | Cystic liver disease (HP:0006706) | 2.38651155 |
| 61 | Lip pit (HP:0100267) | 2.38149527 |
| 62 | Abnormality of the labia majora (HP:0012881) | 2.36324568 |
| 63 | Urinary urgency (HP:0000012) | 2.35948109 |
| 64 | Abnormality of the corticospinal tract (HP:0002492) | 2.35857139 |
| 65 | Decreased circulating renin level (HP:0003351) | 2.32161084 |
| 66 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.31757447 |
| 67 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.30033759 |
| 68 | Hypoplasia of the brainstem (HP:0002365) | 2.30033759 |
| 69 | Horizontal nystagmus (HP:0000666) | 2.29460333 |
| 70 | Widely spaced teeth (HP:0000687) | 2.28730549 |
| 71 | Bronchiectasis (HP:0002110) | 2.28704092 |
| 72 | Menstrual irregularities (HP:0000858) | 2.25984556 |
| 73 | Steppage gait (HP:0003376) | 2.25611729 |
| 74 | Autoamputation (HP:0001218) | 2.25508728 |
| 75 | Aqueductal stenosis (HP:0002410) | 2.24661175 |
| 76 | Supranuclear gaze palsy (HP:0000605) | 2.22379827 |
| 77 | Epileptiform EEG discharges (HP:0011182) | 2.22249284 |
| 78 | Myotonia (HP:0002486) | 2.21657238 |
| 79 | Impaired smooth pursuit (HP:0007772) | 2.21292935 |
| 80 | Neuroendocrine neoplasm (HP:0100634) | 2.20676056 |
| 81 | Arthropathy (HP:0003040) | 2.19358003 |
| 82 | Furrowed tongue (HP:0000221) | 2.18799684 |
| 83 | Abnormality of the nasal septum (HP:0000419) | 2.13613453 |
| 84 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.11014164 |
| 85 | Hyporeflexia of lower limbs (HP:0002600) | 2.09842083 |
| 86 | Lower limb muscle weakness (HP:0007340) | 2.07598153 |
| 87 | Abnormal eating behavior (HP:0100738) | 2.07412881 |
| 88 | Depression (HP:0000716) | 2.06096962 |
| 89 | Failure to thrive in infancy (HP:0001531) | 2.05393035 |
| 90 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.03425449 |
| 91 | Medial flaring of the eyebrow (HP:0010747) | 2.03099987 |
| 92 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.03003821 |
| 93 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.03003821 |
| 94 | Decreased motor nerve conduction velocity (HP:0003431) | 1.99081993 |
| 95 | EEG with generalized epileptiform discharges (HP:0011198) | 1.97827657 |
| 96 | Distal sensory impairment (HP:0002936) | 1.97804944 |
| 97 | Agitation (HP:0000713) | 1.96253362 |
| 98 | Limb dystonia (HP:0002451) | 1.95609366 |
| 99 | Polyphagia (HP:0002591) | 1.95032838 |
| 100 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.94225940 |
| 101 | Dysmetria (HP:0001310) | 1.93876688 |
| 102 | Foot dorsiflexor weakness (HP:0009027) | 1.92399219 |
| 103 | Congenital hepatic fibrosis (HP:0002612) | 1.92370073 |
| 104 | Inability to walk (HP:0002540) | 1.92187047 |
| 105 | Clumsiness (HP:0002312) | 1.90809160 |
| 106 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.90705076 |
| 107 | Abnormality of the ischium (HP:0003174) | 1.90638317 |
| 108 | Abnormality of the fingertips (HP:0001211) | 1.90516305 |
| 109 | Overgrowth (HP:0001548) | 1.89823374 |
| 110 | Abnormal ciliary motility (HP:0012262) | 1.89809005 |
| 111 | Infertility (HP:0000789) | 1.89637554 |
| 112 | Absent speech (HP:0001344) | 1.89614815 |
| 113 | Abnormal hair whorl (HP:0010721) | 1.89370817 |
| 114 | Spastic gait (HP:0002064) | 1.88230289 |
| 115 | Chromsome breakage (HP:0040012) | 1.87990463 |
| 116 | Hyperthyroidism (HP:0000836) | 1.87886982 |
| 117 | Truncal obesity (HP:0001956) | 1.87869523 |
| 118 | Abnormality of chloride homeostasis (HP:0011422) | 1.86983143 |
| 119 | Broad-based gait (HP:0002136) | 1.86688014 |
| 120 | Tubulointerstitial nephritis (HP:0001970) | 1.86525815 |
| 121 | Drooling (HP:0002307) | 1.85665588 |
| 122 | Excessive salivation (HP:0003781) | 1.85665588 |
| 123 | Poor coordination (HP:0002370) | 1.85093548 |
| 124 | Hemiparesis (HP:0001269) | 1.83628683 |
| 125 | Dysdiadochokinesis (HP:0002075) | 1.82609135 |
| 126 | Genetic anticipation (HP:0003743) | 1.82389268 |
| 127 | Aortic aneurysm (HP:0004942) | 1.80024602 |
| 128 | Hypoplastic ischia (HP:0003175) | 1.79009307 |
| 129 | Hypsarrhythmia (HP:0002521) | 1.77736684 |
| 130 | Postural instability (HP:0002172) | 1.76978780 |
| 131 | Atrial fibrillation (HP:0005110) | 1.75640866 |
| 132 | Recurrent corneal erosions (HP:0000495) | 1.75249995 |
| 133 | Onion bulb formation (HP:0003383) | 1.73972738 |
| 134 | Broad distal phalanx of finger (HP:0009836) | 1.73379605 |
| 135 | Poor eye contact (HP:0000817) | 1.72719475 |
| 136 | Scanning speech (HP:0002168) | 1.72573068 |
| 137 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.71911310 |
| 138 | Choroideremia (HP:0001139) | 1.71862839 |
| 139 | Retinal dysplasia (HP:0007973) | 1.71720259 |
| 140 | Lower limb amyotrophy (HP:0007210) | 1.71648942 |
| 141 | Congenital primary aphakia (HP:0007707) | 1.71287830 |
| 142 | Impaired vibratory sensation (HP:0002495) | 1.69772072 |
| 143 | Abnormality of the renal collecting system (HP:0004742) | 1.69466496 |
| 144 | Duplicated collecting system (HP:0000081) | 1.68685752 |
| 145 | Central scotoma (HP:0000603) | 1.68134281 |
| 146 | Type II lissencephaly (HP:0007260) | 1.67636041 |
| 147 | Highly arched eyebrow (HP:0002553) | 1.66284811 |
| 148 | Absent frontal sinuses (HP:0002688) | 1.66246862 |
| 149 | Syncope (HP:0001279) | 1.66213517 |
| 150 | Gait imbalance (HP:0002141) | 1.65982984 |
| 151 | Macroorchidism (HP:0000053) | 1.65271768 |
| 152 | Papillary thyroid carcinoma (HP:0002895) | 1.64532612 |
| 153 | Hamartoma of the eye (HP:0010568) | 1.64440696 |
| 154 | Blue irides (HP:0000635) | 1.64426965 |
| 155 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.63666470 |
| 156 | Volvulus (HP:0002580) | 1.61968205 |
| 157 | Postaxial foot polydactyly (HP:0001830) | 1.61879768 |
| 158 | Midline defect of the nose (HP:0004122) | 1.61624066 |
| 159 | Sandal gap (HP:0001852) | 1.61480797 |
| 160 | Cerebellar dysplasia (HP:0007033) | 1.59242500 |
| 161 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.59123995 |
| 162 | Postural tremor (HP:0002174) | 1.58786249 |
| 163 | Birth length less than 3rd percentile (HP:0003561) | 1.58412467 |
| 164 | Polydipsia (HP:0001959) | 1.58059496 |
| 165 | Abnormal drinking behavior (HP:0030082) | 1.58059496 |
| 166 | Congenital sensorineural hearing impairment (HP:0008527) | 1.57823608 |
| 167 | Depressed nasal tip (HP:0000437) | 1.57229942 |
| 168 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.56862518 |
| 169 | Portal hypertension (HP:0001409) | 1.56813550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.42954135 |
| 2 | NTRK1 | 4.21057234 |
| 3 | RIPK4 | 3.40760371 |
| 4 | ACVR1B | 3.37887337 |
| 5 | MAP3K9 | 2.99630207 |
| 6 | CASK | 2.92203206 |
| 7 | MAP3K4 | 2.69098370 |
| 8 | MINK1 | 2.49412434 |
| 9 | EPHA4 | 2.48625048 |
| 10 | STK39 | 2.45951998 |
| 11 | KSR2 | 2.45166970 |
| 12 | TRPM7 | 2.21045448 |
| 13 | MAP2K7 | 2.10936143 |
| 14 | MATK | 2.07738982 |
| 15 | GRK5 | 2.01774380 |
| 16 | DAPK2 | 2.00397314 |
| 17 | EEF2K | 1.98679388 |
| 18 | MST1R | 1.95537542 |
| 19 | STK38L | 1.94712411 |
| 20 | MAP3K2 | 1.86767847 |
| 21 | PRKD3 | 1.85798512 |
| 22 | PRPF4B | 1.85205326 |
| 23 | PTK2B | 1.76956463 |
| 24 | PDK3 | 1.76080534 |
| 25 | PDK4 | 1.76080534 |
| 26 | LATS1 | 1.64816243 |
| 27 | MAP3K12 | 1.64377587 |
| 28 | MAP2K4 | 1.63472900 |
| 29 | CDK12 | 1.58693407 |
| 30 | SGK2 | 1.55466150 |
| 31 | CAMK1D | 1.53766866 |
| 32 | PAK6 | 1.53623900 |
| 33 | MET | 1.51896346 |
| 34 | FER | 1.51451543 |
| 35 | TGFBR1 | 1.46793377 |
| 36 | SIK3 | 1.45625400 |
| 37 | SGK494 | 1.43677154 |
| 38 | SGK223 | 1.43677154 |
| 39 | CAMKK2 | 1.38746514 |
| 40 | DAPK1 | 1.34453742 |
| 41 | RET | 1.33234940 |
| 42 | TIE1 | 1.29516436 |
| 43 | PIK3CA | 1.28796998 |
| 44 | MKNK2 | 1.27482108 |
| 45 | MYLK | 1.27014739 |
| 46 | EPHA3 | 1.26762579 |
| 47 | OXSR1 | 1.26225088 |
| 48 | PLK2 | 1.25250725 |
| 49 | LMTK2 | 1.25231801 |
| 50 | AKT3 | 1.24493528 |
| 51 | MELK | 1.24037458 |
| 52 | MAPK15 | 1.23992550 |
| 53 | INSRR | 1.21760759 |
| 54 | MAPK13 | 1.19385936 |
| 55 | PRKCG | 1.16471083 |
| 56 | BRSK2 | 1.15725451 |
| 57 | ADRBK2 | 1.12446456 |
| 58 | CDK5 | 1.12341513 |
| 59 | ARAF | 1.12103944 |
| 60 | SGK3 | 1.09315568 |
| 61 | NLK | 1.07863214 |
| 62 | LATS2 | 1.06140233 |
| 63 | MAP2K1 | 1.06044030 |
| 64 | PDK2 | 1.05547603 |
| 65 | MARK1 | 1.05536376 |
| 66 | WNK4 | 1.04230588 |
| 67 | KSR1 | 1.02946724 |
| 68 | TESK1 | 1.01515468 |
| 69 | STK24 | 1.00030793 |
| 70 | PRKCE | 0.95222187 |
| 71 | NUAK1 | 0.94542261 |
| 72 | PRKAA2 | 0.93041357 |
| 73 | MAP3K7 | 0.92563628 |
| 74 | MARK3 | 0.88999017 |
| 75 | CAMK2A | 0.87873327 |
| 76 | CAMKK1 | 0.87576735 |
| 77 | NEK9 | 0.86979673 |
| 78 | STK3 | 0.85366606 |
| 79 | CSNK1A1L | 0.85142629 |
| 80 | FES | 0.85020123 |
| 81 | BRD4 | 0.81283587 |
| 82 | NTRK2 | 0.81190580 |
| 83 | GRK1 | 0.80780231 |
| 84 | PDK1 | 0.79611696 |
| 85 | DMPK | 0.78960113 |
| 86 | PNCK | 0.74696404 |
| 87 | RPS6KA2 | 0.73468892 |
| 88 | FGFR2 | 0.73266491 |
| 89 | MAPKAPK5 | 0.73021053 |
| 90 | MAP3K1 | 0.72636356 |
| 91 | PDPK1 | 0.72216301 |
| 92 | CDK14 | 0.70783223 |
| 93 | STK38 | 0.67300181 |
| 94 | CHUK | 0.67278897 |
| 95 | ADRBK1 | 0.65521155 |
| 96 | FRK | 0.65161500 |
| 97 | PRKAA1 | 0.62783880 |
| 98 | CAMK2B | 0.59393448 |
| 99 | LIMK1 | 0.57993115 |
| 100 | GRK7 | 0.57639198 |
| 101 | CDK18 | 0.57388816 |
| 102 | OBSCN | 0.56744536 |
| 103 | MAP3K13 | 0.55397586 |
| 104 | MAPK11 | 0.54228863 |
| 105 | CSNK1G2 | 0.54007351 |
| 106 | MTOR | 0.52911916 |
| 107 | TEC | 0.51648807 |
| 108 | EPHA2 | 0.51560706 |
| 109 | BRAF | 0.51214915 |
| 110 | MST4 | 0.50936304 |
| 111 | ERBB3 | 0.50783964 |
| 112 | PINK1 | 0.50549810 |
| 113 | RPS6KB2 | 0.49793611 |
| 114 | MAP4K2 | 0.49504841 |
| 115 | PHKG1 | 0.48561311 |
| 116 | PHKG2 | 0.48561311 |
| 117 | YES1 | 0.48557619 |
| 118 | CAMK1G | 0.48244366 |
| 119 | CDK15 | 0.47927900 |
| 120 | MARK2 | 0.47308974 |
| 121 | PDGFRA | 0.47157619 |
| 122 | PTK2 | 0.46771266 |
| 123 | PRKCZ | 0.46043804 |
| 124 | CAMK4 | 0.44704512 |
| 125 | BMPR1B | 0.44469481 |
| 126 | SGK1 | 0.44429072 |
| 127 | TAF1 | 0.43994200 |
| 128 | CCNB1 | 0.42559767 |
| 129 | JAK1 | 0.42399659 |
| 130 | PRKCH | 0.41711739 |
| 131 | PAK3 | 0.41676400 |
| 132 | PRKG2 | 0.41227262 |
| 133 | BCR | 0.39162587 |
| 134 | ATM | 0.39026101 |
| 135 | WNK3 | 0.38977594 |
| 136 | CAMK2D | 0.38871967 |
| 137 | CDC42BPA | 0.37289292 |
| 138 | WNK1 | 0.37099810 |
| 139 | CDK3 | 0.36893803 |
| 140 | CSNK1G1 | 0.35064097 |
| 141 | CDK11A | 0.34189735 |
| 142 | TNIK | 0.34094683 |
| 143 | PDGFRB | 0.33803906 |
| 144 | MAPK7 | 0.32897293 |
| 145 | SRC | 0.32105629 |
| 146 | NEK6 | 0.31877987 |
| 147 | MAPKAPK3 | 0.31378181 |
| 148 | PRKACA | 0.30801786 |
| 149 | PRKCB | 0.30517188 |
| 150 | MAPK10 | 0.30514016 |
| 151 | ITK | 0.30400835 |
| 152 | CAMK1 | 0.27718979 |
| 153 | RPS6KA3 | 0.27392767 |
| 154 | STK11 | 0.27048576 |
| 155 | CAMK2G | 0.26437142 |
| 156 | FGR | 0.25372039 |
| 157 | BMPR2 | 0.25087978 |
| 158 | FGFR3 | 0.24924037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.04980432 |
| 2 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.74577471 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.56853590 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.46782818 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.42608973 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.39463194 |
| 7 | Insulin secretion_Homo sapiens_hsa04911 | 2.27966868 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.26979623 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.17507966 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.10830600 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.09147530 |
| 12 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.08427669 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.00954047 |
| 14 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.97447223 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.96429414 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.93092608 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 1.87669977 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81036953 |
| 19 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.80603611 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.80380980 |
| 21 | ABC transporters_Homo sapiens_hsa02010 | 1.68947140 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.67950077 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.66499449 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.66427600 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.61041851 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.57904097 |
| 27 | GABAergic synapse_Homo sapiens_hsa04727 | 1.55968572 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.55462822 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.52588177 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46953217 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.40185705 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.39999766 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.36553079 |
| 34 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.33509892 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.32141031 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.31831122 |
| 37 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.31711744 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.28582959 |
| 39 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.18950693 |
| 40 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.15568656 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14938336 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.14481789 |
| 43 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.14141951 |
| 44 | Adherens junction_Homo sapiens_hsa04520 | 1.13410235 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.11485503 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08788526 |
| 47 | Glioma_Homo sapiens_hsa05214 | 1.07385091 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04691969 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.02620198 |
| 50 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.01852169 |
| 51 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.01304316 |
| 52 | Tight junction_Homo sapiens_hsa04530 | 0.99179084 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.98625935 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.98273649 |
| 55 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.97464399 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.97019052 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.96366604 |
| 58 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93832117 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.93525820 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.93518668 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.91277306 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90784088 |
| 63 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89716650 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.89099145 |
| 65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.88813686 |
| 66 | Axon guidance_Homo sapiens_hsa04360 | 0.88707624 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87996996 |
| 68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86368974 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.85354952 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85070885 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84235084 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83992697 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83162273 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81665369 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.81528208 |
| 76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.80991397 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77822082 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77588941 |
| 79 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75564601 |
| 80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.75203026 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.74900848 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74677079 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73720752 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71083798 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70711897 |
| 86 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.70409752 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70063425 |
| 88 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.69773515 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69380419 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.68247278 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.68129608 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65060678 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64276157 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63768880 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63409419 |
| 96 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62853853 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62579293 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61086463 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60665480 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60425951 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.59438977 |
| 102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58417251 |
| 103 | Melanoma_Homo sapiens_hsa05218 | 0.55689508 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55389497 |
| 105 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55354408 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.54736460 |
| 107 | Bile secretion_Homo sapiens_hsa04976 | 0.53896393 |
| 108 | Prostate cancer_Homo sapiens_hsa05215 | 0.51785929 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51391984 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.51002446 |
| 111 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49018798 |
| 112 | Salmonella infection_Homo sapiens_hsa05132 | 0.48682236 |
| 113 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.48541131 |
| 114 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46625063 |
| 115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44762599 |
| 116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43392313 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43391890 |
| 118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43113582 |
| 119 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42722094 |
| 120 | Phototransduction_Homo sapiens_hsa04744 | 0.42260380 |
| 121 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42103806 |
| 122 | Basal transcription factors_Homo sapiens_hsa03022 | 0.41489846 |
| 123 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.41055197 |
| 124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40738690 |
| 125 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40594694 |
| 126 | Alcoholism_Homo sapiens_hsa05034 | 0.40266917 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39802988 |
| 128 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39748305 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39682895 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.39505276 |
| 131 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38987656 |
| 132 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38697800 |
| 133 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35682788 |
| 134 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.35202148 |
| 135 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34945301 |
| 136 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33602195 |
| 137 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32396417 |
| 138 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.30244337 |
| 139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29528617 |

